ICON PLC reports long-delayed full-year 2025 results on Monday, March 9, as investors brace for the first financial disclosure since the clinical research organization disclosed an internal accounting ...
ICON expects market conditions to remain similar through year-end, assuming persistent cancellation rates and mixed timing on biotech conversions. The company raised its full year revenue guidance to ...
Icon Plc (NASDAQ: ICLR) shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing ...
Hosted on MSN
Icon outlines $8.05B-$8.1B 2025 revenue target as margin pressure persists, supported by strong RFP flow
Earnings Call Insights: ICON Public Limited Company (ICLR) Q3 2025 Steven Cutler reflected on his tenure, noting ICON's growth from 8,500 to 40,000 employees and its rise in industry ranking. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results